9.11
-0.08
(-0.87%)
At close: January 31 at 8:16:34 AM GMT+1
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.58M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| DONHAUSER PETER D.O. Director | Purchase at price 3.64 per share. | Direct | 10,319 | Jun 14, 2024 |
| THOMAS STEFFEN PHD Director | Purchase at price 4.52 per share. | Direct | 22,600 | May 15, 2024 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Conversion of Exercise of derivative security at price 1.32 per share. | Direct | 96,862 | Mar 28, 2024 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Sale at price 5.11 per share. | Direct | 374,972 | Mar 28, 2024 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Conversion of Exercise of derivative security at price 1.60 per share. | Direct | 800,000 | Jun 29, 2023 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Sale at price 7.98 per share. | Direct | 2,139,310 | Jun 28, 2023 |
Related Tickers
19X.SG Axsome Therapeutics Inc
102.25
-2.01%
I9SA.HA Verona Pharma PLC
55.00
+0.92%
TRRI Alzex Neuropharma Inc.
0.1980
0.00%
HALB Halberd Corporation
0.0034
+13.33%
RAPP Rapport Therapeutics, Inc.
16.41
-1.44%
NAMS NewAmsterdam Pharma Company N.V.
22.29
+2.39%
PCVX Vaxcyte, Inc.
88.32
-3.95%
DAWN Day One Biopharmaceuticals, Inc.
12.37
-3.81%
IBIO iBio, Inc.
3.0100
+1.35%
CELZ Creative Medical Technology Holdings, Inc.
3.1300
-7.40%